PAK4-targeted PROTACs in clear cell renal cell carcinoma: a two-for-one targeted and immune therapy?

• Ziad Bakouny,
• David A. Braun,
• Ed Reznik,
• A. Ari Hakimi

Affiliations

Ziad Bakouny

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Corresponding author. Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.

David A. Braun

Center of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA

Ed Reznik

Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA

A. Ari Hakimi

Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA